Bristol Myers Squibb (BMS)

Wire

Bristol Myers Squibb Announces CEO Transition and New Board Chair
ByNNR November 1, 2023November 1, 2023

NEW YORK: Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has unanimously elected Christopher Boerner, Ph.D., to serve as Chair of the Board, effective April 1, 2024. He succeeds Giovanni Caforio, M.D., who will step down…

Read More Bristol Myers Squibb Announces CEO Transition and New Board Chair
Companies listed on New York Stock Exchange

Bristol Myers Squibb (BMS)
ByNNR December 2, 2020December 27, 2023

Bristol Myers Squibb (BMS) is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. BMS’s primary…

Read More Bristol Myers Squibb (BMS)

Exit mobile version